FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Feb 9, 2017
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on February 9, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8bd254b3-7211-44ca-a23f-fe75896b2042
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1003172
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 16, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma Inc.
- FDA Inspection 1108997 - 2019-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.